Показать сообщение отдельно
  #14  
Старый 28.06.2011, 02:34
Dr.Anisimova Dr.Anisimova вне форума ВРАЧ
Почетный участник форума
      
 
Регистрация: 16.01.2007
Город: РФ
Сообщений: 14,319
Сказал(а) спасибо: 6
Поблагодарили 5,347 раз(а) за 4,983 сообщений
Dr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форумеDr.Anisimova этот участник имеет превосходную репутацию на форуме
- хороший шампунь, да не наш("клобекс", "clobex", некоторым пациентам с псориазом волос. части головы хотя бы, удается заказать)
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study
[Ссылки доступны только зарегистрированным пользователям ]

The International Journal of Trichology (IJT)
- "перхоть"
A new postulate on two stages of dandruff: A clinical perspective
[Ссылки доступны только зарегистрированным пользователям ]

Clinical photography for trichology practice: Tips and tricks
[Ссылки доступны только зарегистрированным пользователям ]

Randomized comparison of topical betamethasone valerate foam, intralesional triamcinolone acetonide and tacrolimus ointment in management of localized alopecia areata
[Ссылки доступны только зарегистрированным пользователям ]
Conclusion: Intralesional triamcinolone acetonide is the best, betamethasone valerate foam is better than tacrolimus in management of localized AA.

Graham-Little Piccardi Lassueur syndrome: An unusual variant of follicular lichen planus
[Ссылки доступны только зарегистрированным пользователям ]
Graham Little-Piccardi-Lassueur syndrome is a type of lichen planopilaris (follicular lichen planus) characterized by the triad of patchy cicatricial alopecia of the scalp, noncicatricial alopecia of the axilla and groin, and a follicular spinous papule on the body, scalp, or both. It is four times more common in females in the age group of 30-70 years. Only a few cases have been reported in literature wherein the disease has affected males. Herein we report a young male who presented with features of Graham Little-Piccardi-Lassueur syndrome.

Malherbe's calcifying epithelioma (pilomatrixoma): An uncommon periocular tumor
[Ссылки доступны только зарегистрированным пользователям ]

Localised acquired trichorrhexis nodosa of the scalp hair induced by a specific comb and combing habit - A report of three cases
[Ссылки доступны только зарегистрированным пользователям ]
Trichorrhexis nodosa is a hair shaft disorder often encountered in clinical practice. Acquired trichorrhexis is commoner of the two types and is most often due to weathering from physical or chemical causes. We report three representative cases of localized acquired trichorrhexis encountered in our clinic attributable to a specific comb, used commonly in Kerala, a Southern state of India.

Hypertrichosis due to congenital hypothyroidism
[Ссылки доступны только зарегистрированным пользователям ]
In conclusion, we suggest that full assessment of thyroid function be carried out in all cases of hypertrichosis or abnormal distribution of body hair.

Congenital triangular alopecia: A close mimicker of alopecia areata
[Ссылки доступны только зарегистрированным пользователям ]

Alopecia areata - probing the deforestation
[Ссылки доступны только зарегистрированным пользователям ]
A variety of treatment options such as phototoxic psoralen and ultraviolet-A therapy after topical application of 0.1% 8-methoxypsoralen, diphencyprone, dinitrochlorobenzene, squaric acid dibutylester, steroids, minoxidil, anthralin, and bexarotene have shown promise in managing AA.

Light microscopy of the hair: A simple tool to "untangle" hair disorders
[Ссылки доступны только зарегистрированным пользователям ]

Sebaceous gland loss and inflammation in scarring alopecia: A*potential role in pathogenesis.
[Ссылки доступны только зарегистрированным пользователям ]
Conclusions
This study demonstrates that sebaceous gland loss is a common and early finding among SA. In addition, sebaceous gland and/or duct inflammation may play a role in initiating or accelerating follicular damage during the development of SA.

Isoniazid-induced alopecia
[Ссылки доступны только зарегистрированным пользователям ]
Isoniazid is a safe and very effective antituberculosis drug. Antimitotic agents routinely cause alopecia. Drug-induced alopecia is usually reversible upon withdrawal of the drug. Isoniazid, thiacetazone and ethionamide are the antituberculosis drugs which have been associated with alopecia. Isoniazid-induced alopecia was observed in one case and confirmed by the finding that hair growth resumed when drug removed from the regimen.

CONFOCAL MICROSCOPIC FEATURES OF SCARRING ALOPECIA: PRELIMINARY REPORT
[Ссылки доступны только зарегистрированным пользователям ]
Conclusion: in our preliminary study it seems to be evident the effective usefulness of RCM for scarring alopecias diagnosis and follow-up. Moreover, RCM seems to be also promising for differential diagnosis between the different entities.

Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
[Ссылки доступны только зарегистрированным пользователям ]
The role of genetic predisposition and the influence of sex steroid hormones are indisputable to the pathogenesis of male androgenetic alopecia (MAGA). The role of sex steroid hormones in female pattern hair loss (FPHL) is less known. A good knowledge of the pathophysiology underlying MAGA and FPHL empowers the clinician to confidently counsel patients and make informed therapeutic decisions. Vigorous research in recent years has provided greater insight into the role of genetics and sex steroids in physiological hair growth and cycling, as well as in hair follicle miniaturization, the histological hallmark of MAGA and FPHL. In the present review article directed towards clinicians, we discuss the current understanding of the role of androgens and oestrogens, as well as genetic associations with MAGA and FPHL. We also briefly discuss the interpretation of direct-to-consumer genetic testing for baldness to help clinicians understand the limitations of such tests.
MAGA and FPHL are distinct clinical entities with overlap in some underlying biomolecular mechanisms that lead to histologically indistinguishable hair follicle miniaturization. Genetic predisposition and sex steroid hormones are prerequisites to both conditions, although their full genetic risk profiles and the role of androgens and oestrogens in both conditions remain to be more accurately defined through further research work. Decoding of the full genetic risk profile of baldness is not unforeseeable with rapidly expanding large-scale genotyping technology, which makes pharmacogenetic risk profiling for the individualization of baldness treatments a possible goal.

Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study
[Ссылки доступны только зарегистрированным пользователям ]
Conclusion The frequencies of autoimmune and atopic diseases were not different between adult and paediatric patients and the control group. We did not find a statistically significance between disease severity and personal and family history of autoimmune disease in the two groups. Disease severity was not related to nail changes in the adult group. However, severe alopecia areata was more prevalent in children with nail changes. Furthermore, ophiasis pattern was more prevalent in the paediatric group with nail changes compared with the adult group.

- миноксидил/регейн 5% пена 1 раз в день сопоставима с 2-х кратным использованием обычного 2% регейна у женщин(АГА)
A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
[Ссылки доступны только зарегистрированным пользователям ]
Conclusions
Once-daily 5% MTF is noninferior and as effective for stimulating hair growth as twice-daily 2% MTS in women with androgenetic alopecia and is associated with several aesthetic and practical advantages.

Lichenoid red tatoo reaction and alopecia areata
[Ссылки доступны только зарегистрированным пользователям ]

Specular light reflectance of flakes in seborrhoeic dermatitis of the scalp: a pilot study
[Ссылки доступны только зарегистрированным пользователям ]

Evidence of increased DNA methylation of the androgen receptor gene in occipital hair follicles from men with androgenetic alopecia
[Ссылки доступны только зарегистрированным пользователям ]